Insider Transactions in Q4 2020 at Zymeworks Inc. (ZYME)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2020
|
Neil A Klompas Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
25,000
-73.27%
|
$1,325,000
$53.25 P/Share
|
|
Dec 09
2020
|
Neil A Klompas Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+32.57%
|
$100,000
$4.93 P/Share
|
|
Dec 07
2020
|
Ali Tehrani Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
850
-1.51%
|
$47,600
$56.16 P/Share
|
|
Dec 04
2020
|
Diana Hausman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,032
-61.87%
|
$331,760
$55.12 P/Share
|
|
Dec 04
2020
|
Diana Hausman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,032
+27.43%
|
$60,320
$10.83 P/Share
|
|
Dec 02
2020
|
Diana Hausman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
701
-15.86%
|
$38,555
$55.01 P/Share
|
|
Dec 02
2020
|
Diana Hausman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
701
+7.35%
|
$7,010
$10.83 P/Share
|
|
Dec 01
2020
|
Diana Hausman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
18,267
-83.09%
|
$1,004,685
$55.19 P/Share
|
|
Dec 01
2020
|
Diana Hausman Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,267
+36.8%
|
$182,670
$10.83 P/Share
|
|
Nov 18
2020
|
Kathryn O'Driscoll Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,920
+50.0%
|
$99,280
$34.24 P/Share
|
|
Nov 02
2020
|
Ali Tehrani Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
3,500
-5.85%
|
$136,500
$39.04 P/Share
|